Disruption of Epithelial Barrier Integrity via Altered GILZ/c-Rel/RACK1 Signaling in Inflammatory Bowel Disease - Summary - MDSpire

Disruption of Epithelial Barrier Integrity via Altered GILZ/c-Rel/RACK1 Signaling in Inflammatory Bowel Disease

  • By

  • Erica Buoso

  • Mirco Masi

  • Roberta Valeria Limosani

  • Francesca Fagiani

  • Chiara Oliviero

  • Giorgia Colombo

  • Luigi Cari

  • Marco Gentili

  • Eleonora Lusenti

  • Lucrezia Rosati

  • Federica Pisati

  • Alessandra Pasini

  • Marco Vincenzo Lenti

  • Antonio Di Sabatino

  • Claire Louise Mobbs

  • Stefan Przyborski

  • Simona Ronchetti

  • Cristina Travelli

  • Marco Racchi

  • December 18, 2024

  • 0 min

Share

Objective:

To investigate the role of RACK1 in inflammatory bowel disease (IBD) and its correlation with GILZ expression and its impact on epithelial barrier integrity.

Key Findings:
  • RACK1 expression is significantly decreased in IBD, particularly in ulcerative colitis, indicating a potential biomarker.
  • Decreased GILZ protein expression correlates with reduced RACK1 levels, suggesting a regulatory relationship.
  • GILZ depletion leads to SRC activation and reduced E-cadherin, impairing epithelial barrier integrity, which may exacerbate IBD symptoms.
  • Dexamethasone restores RACK1 expression independently of the c-Rel/GILZ pathway, highlighting a potential therapeutic mechanism.
Interpretation:

The alteration of the RACK1/SRC/E-cadherin regulatory mechanism linked to decreased GILZ expression contributes to epithelial barrier disruption in IBD, suggesting new avenues for treatment.

Limitations:
  • The study primarily focuses on specific signaling pathways and may not encompass all mechanisms involved in IBD, potentially limiting the applicability of findings.
  • Results from animal models may not fully translate to human IBD pathology, necessitating further clinical validation.
Conclusion:

The findings suggest that targeting the GILZ/c-Rel/RACK1 signaling pathway could lead to novel therapeutic strategies for IBD, particularly in glucocorticoid-resistant patients, warranting further investigation.

Original Source(s)

Disruption of Epithelial Barrier Integrity via Altered GILZ/c-Rel/RACK1 Signaling in Inflammatory Bowel Disease

  • by Erica Buoso, Mirco Masi, Roberta Valeria Limosani, Francesca Fagiani, Chiara Oliviero, Giorgia Colombo, Luigi Cari, Marco Gentili, Eleonora Lusenti, Lucrezia Rosati, Federica Pisati, Alessandra Pasini, Marco Vincenzo Lenti, Antonio Di Sabatino, Claire Louise Mobbs, Stefan Przyborski, Simona Ronchetti, Cristina Travelli, Marco Racchi

  • December 18, 2024

Related Content

Therapeutic Approaches for Inflammatory Bowel Disease: The Role of Immunomodulators, Biologics, and 5-Aminosalicylates in Cardiovascular Risk Management

The role of lipid metabolism and creeping fat in disease assessment and prediction for Crohn’s disease

Evaluation of 5-Aminosalicylic Acid Utilization in Crohn’s Disease Management: Insights from a Nationwide Survey of Inflammatory Bowel Disease Specialists